SUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes

Pancreatic ß cell dysfunction is a key feature of type 2 diabetes, and novel regulators of insulin secretion are desirable. Here, we report that succinate receptor 1 (SUCNR1) is expressed in ß cells and is upregulated in hyperglycemic states in mice and humans. We found that succinate acted as a hor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of clinical investigation 2024-06, Vol.134 (12), p.1-15
Hauptverfasser: Sabadell-Basallote, Joan, Astiarraga, Brenno, Castaño, Carlos, Ejarque, Miriam, Repollés-de-Dalmau, Maria, Quesada, Ivan, Blanco, Jordi, Núñez-Roa, Catalina, Rodríguez-Peña, M-Mar, Martínez, Laia, Dejesus, Dario F, Marroquí, Laura, Bosch, Ramon, Moritanya, Eduard, Sureda, Francesc X, Tura, Andrea, Mari, Andrea, Kulkarni, Rohit N, Vendrell, Joan, Fernández-Veledo, Sonia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Pancreatic ß cell dysfunction is a key feature of type 2 diabetes, and novel regulators of insulin secretion are desirable. Here, we report that succinate receptor 1 (SUCNR1) is expressed in ß cells and is upregulated in hyperglycemic states in mice and humans. We found that succinate acted as a hormone-like metabolite and stimulated insulin secretion via a SUCNR1-Gq-PKC-dependent mechanism in human ß cells. Mice with ß cell-specific Sucnrl deficiency exhibited impaired glucose tolerance and insulin secretion on a high-fat diet, indicating that SUCNR1 is essential for preserving insulin secretion in diet-induced insulin resistance. Patients with impaired glucose tolerance showed an enhanced nutrition-related succinate response, which correlates with the potentiation of insulin secretion during intravenous glucose administration. These data demonstrate that the succinate/SUCNRI axis is activated by high glucose and identify a GPCR-mediated amplifying pathway for insulin secretion relevant to the hyperinsulinemia of prediabetic states.
ISSN:0021-9738
1558-8238
DOI:10.1172/JCI173214.